Dr. Sukanya Bhrugumalla, Gastroenterologist
MBBS, MD, DM (Gastro)
Gastroenterologist
Dr. Sukanya Bhrugumalla Appointment and Practice Location
Punjagutta Road, Punjagutta Market,
Panjagutta, Hyderabad
Get Directions
OP Timings
Mon - Sat
08:00 am - 11:00 am
Fee: 100
- Practice Locations (1)
- Profile
- Patient Reviews
- Q&A
- Media
Specializations
Gastroenterologist
Qualifications
- MBBS
- MD
- DNB - Gastroenterology
Experiences
- Consultant Gastroenterologist Nizams Institute of Medical Sciences - Panjagutta - Currently Working
Memberships
- Indian Society of Gastroenterology
- Indian Society for the Study of Liver Diseases
Paper Presentations
- Co Investigator in Global Multicentre Phase II Trial - GI-5005 Therapeutic Vaccine Plus Peg - IFN/Ribavirin Improves End of Treatment Response at 48 Weeks Versus Peg - IFN/Ribavirin in Nave Genotype 1 Chronic HCV Patient 2008
- Co Investigator in Global Multicentre Phase II Trial - An Evaluation of 2 Dose Routes of HDV Interferon (HDV-IFN) Administered with Ribavirin in the Treatment of Chronic Hepatitis C Non Responder and Naive Hepatitis C Patients 2008
- Co Investigator in Global Multicentre Phase III Trial - Open Labeled, Randomised, Multicentre, Active-Controlled, Dose Ranging Study to Evaluate The Safety and Efficacy of Albinterferon Alfa-2b Administered Every 4 Weeks Plus Ribavirin in Interferon Alfa Naive Patients with Genotype 2/3 Chronic Hepatitis C 2009
- Co Investigator in Global Multicentre Phase II Trial - Randomised, Double Blind, Placebo Controlled, Phase 2b Study to Assess the Safety and Efficacy Effects of Art -123 on Subjects with Sepsis and Dsseminated Intravascular Coagulation 2010
- Principle Investigator in Nationwide Multicentre Phase III Trial - Single Dose Delayed Released Mesalamine in Moderately Active Ulcerative Colitis 2011
- Co Investigator in Nationwide Multicentre Phase IV Trial - Open Label Study to Evaluate the Safety and Efficacy of Amphotericin B Lipid Suspension for Injection (Amfy) in Immunocompromised Patients with Invasive Fungal Infections (IFI) 2011
- Co Investigator in THE APPROACH STUDY - Safety and Efficacy of Boceprevir in Combination with Peg Interferon Plus Ribavirin for Treatment of Asia Pacific Subjects with Chronic Hepatitis C Genotype 1 who Failed Prior Treatment with Pegylated Interforon Plus Ribavirin 2013
Report an error
Dr. Sukanya Bhrugumalla, Gastroenterologist Reviews
No feedback available for this Doctor.
Be the first to write a review.
Question & Answers by Dr. Sukanya Bhrugumalla
No Question & Answers by this doctor.
Media from Dr. Sukanya Bhrugumalla
No Videos updated by this doctor.
